Dawn Svoronos, Director at Xenon Pharmaceuticals Inc. (XENE), sold 50,000 shares at $38.70 ($1.9M) on 2023-08-24, disclosed to the SEC on 2023-08-24.
Open-market sale of $1.9M XENE by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $38.70 | 25,000 | $968K | 50.0% |
| 2 | $38.70 | 25,000 | $968K | 50.0% |
| Total | $38.70 avg | 50,000 | $1.9M | 100% |
| Filing → |
| PTCT | SELL | 2022-06-10 | $20K | — | Filing → |
| ADVM | BUY | 2022-05-18 | $26K | — | Filing → |
| PTCT | SELL | 2022-01-11 | $20K | — | Filing → |